Professional Summary

Professional Overview

Katie Nifong is an accomplished finance executive with extensive experience in the pharmaceutical and drug development industry. As the Executive Director of Finance at Labcorp Drug Development, she leverages her expertise in financial planning, analysis, and strategy to drive the organization's long-term growth and profitability.

Experience Summary

Current Role

In her current role as Executive Director of Finance at Labcorp Drug Development, Katie is responsible for overseeing the company's financial operations, including budgeting, forecasting, and performance analysis. She plays a crucial role in aligning the organization's financial strategies with its overall business objectives, ensuring effective resource allocation and decision-making.

Career Progression

Prior to her current position, Katie held various leadership roles within the Covance organization, which was later acquired by Labcorp. As the Executive Director and Head of Early Development Finance, she spearheaded the financial management of Labcorp's early-stage drug development services, demonstrating her ability to navigate complex financial challenges and deliver sustainable results. She has also served as the Director and Associate Director of Corporate FP&A, where she honed her skills in financial planning, analysis, and reporting.

Early in her career, Katie gained valuable experience as a Senior Staff Auditor at Crowe Horwath LLP, where she developed a deep understanding of financial controls and compliance.

Academic Background

Katie holds a Bachelor's degree in Accounting from the University of Illinois at Urbana-Champaign, where she graduated with distinction.

Areas of Expertise

• Financial planning and analysis

• Budgeting and forecasting

• Performance management and reporting

• Strategic financial decision-making

• Financial process optimization

• Financial compliance and controls

• Cross-functional collaboration

Professional Impact

Throughout her career, Katie has played a pivotal role in driving financial excellence and supporting the growth of the organizations she has served. Her ability to translate complex financial data into actionable insights has enabled her to contribute to key strategic initiatives, enhance operational efficiency, and drive measurable improvements in financial performance.

Conclusion

With her proven track record of success, Katie Nifong is a strategic finance leader who continues to make a significant impact in the pharmaceutical and drug development industry. Her comprehensive expertise, coupled with her ability to navigate changing market dynamics, positions her as a valuable asset to Labcorp Drug Development as they navigate the evolving landscape of the industry.